This two-part series is intended to assist family physicians in the management of patients who have atrial fibrillation, with an emphasis on reducing their risk of stroke.
The series will review ACC/AHA clinical practice guidelines and other evidence-based recommendations. Application of these recommendations with carefully reasoned clinical judgment can help reduce the risk of stroke in patients with atrial fibrillation.
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Thromboprophylaxis in Atrial Fibrillation
Series Overview
Series Objectives
After completing the activities in this series, family physicians will be better able to:
- Demonstrate increased awareness of the range of assessment tools and evidence-based guidelines available to aid thrombotic risk stratification in AF and incorporate this knowledge into practice.
- Describe the role of antithrombotic therapy in AF patients at risk of stroke and be aware of the implications of underprescribing.
- Describe the safety and efficacy profile of the currently available antithrombotic therapies, including issues surrounding patient selection.
- Describe the approach to dosing and therapeutic drug monitoring for antithrombotic therapy in AF patients at risk of stroke based on evidence-based guidelines, and incorporate this knowledge into practice.
- Outline strategies for risk reduction in challenging patient populations and incorporate this knowledge into practice.
- Describe emerging antithrombotic therapies and other new developments in the prevention of stroke in AF, including issues surrounding patient selection and monitoring.
Accessing the CME Activities
LearningLink is hosted by AAFP's technology partner MedEdArchitects. To access the activities (and to allow us to track learner progress through the program), you will need a LearningLink account. The only information required is your name, email address and member status. Create a LearningLink account.
Activity 1: Thromboprophylaxis in Atrial Fibrillation: Current Issues and Challenges
-- The first in a two-part series addressing the challenges of preventing stroke in patients with atrial fibrillation, this activity reviews risk stratification and pharmacologic options.
Activity 2: Thrombophylaxis in Atrial Fibrillation: A Case-Based Approach to Management
-- The second in a two-part series, this activity features patient cases that review the fundamentals of thrombophylaxis in patients with atrial fibrillation. Cases focus on deciding between anticoagulants and antiplatelet agents, balancing bleeding risk against stroke risk, and the therapeutic role of new anticoagulant agents.
Acknowledgment of Support
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
AAFP LearningLink
